ΔNp73/ETS2 complex drives glioblastoma pathogenesis- targeting downstream mediators by rebastinib prolongs survival in preclinical models of glioblastoma.

Authors

Maren Cam
Manish Charan
Alessandra M. Welker
Piyush Dravid
Adam W. Studebaker
Jeffrey R. Leonard
Christopher R. Pierson
Ichiro Nakano
Christine E. Beattie
Eugene I. Hwang, George Washington University
Madhuri Kambhampati
Javad Nazarian, George Washington University
Jonathan L. Finlay
Hakan Cam

Document Type

Journal Article

Publication Date

11-25-2019

Journal

Neuro-Oncology

DOI

10.1093/neuonc/noz190

Comments

Epub ahead of print

APA Citation

Cam, M., Charan, M., Welker, A. M., Dravid, P., Studebaker, A. W., Leonard, J. R., Pierson, C. R., Nakano, I., Beattie, C. E., Hwang, E. I., Kambhampati, M., Nazarian, J., Finlay, J. L., & Cam, H. (2019). ΔNp73/ETS2 complex drives glioblastoma pathogenesis- targeting downstream mediators by rebastinib prolongs survival in preclinical models of glioblastoma.. Neuro-Oncology, (). http://dx.doi.org/10.1093/neuonc/noz190

Peer Reviewed

1